Maxi Zumpe
8PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 14, 2025
Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition.Sascha Troschke-Meurer, Maxi Zumpe, Peter Moritz Ahrenberg
|Jul 14, 2023
Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.Holger N Lode, Ruth Ladenstein, Sascha Troschke-Meurer
|Jul 14, 2023
Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta.Nikolai Siebert, Maxi Zumpe, Christian Heinrich Schwencke
|Mar 29, 2023
A 3D Model of Human Buccal Mucosa for Compatibility Testing of Mouth Rinsing Solutions.Paula Zwicker, Maxi Zumpe, Axel Kramer
|Feb 11, 2023
Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models.Sascha Troschke-Meurer, Maxi Zumpe, Lena Meißner
|Dec 11, 2022
Immune Response and Outcome of High-Risk Neuroblastoma Patients Immunized with Anti-Idiotypic Antibody Ganglidiomab: Results from Compassionate-Use Treatments.Leah Klingel, Nikolai Siebert, Sascha Troschke-Meurer
Pageof 2
Frequent Collaborators
7 joint publications
Sascha Troschke-Meurer
6 joint publications
Holger N Lode
4 joint publications
Nikolai Siebert
1 joint publications
Sascha Marx
1 joint publications
Madlen Marx
1 joint publications
Claudia Maletzki
1 joint publications
Sander Bekeschus
1 joint publications
Paula Zwicker
1 joint publications
Karoline Ehlert
1 joint publications
Angelika Eggert
